Remetinostat
Catalog No. A12149
Remetinostat (SHP-141) is a hydroxamic acid-based inhibitor of histone deacetylase enzymes (HDAC) which is under development for the treatment of cutaneous T-cell lymphoma.
| Catalog Num | A12149 |
|---|---|
| M. Wt | 323.34 |
| Formula | C6H21NO6 |
| Purity | >98% |
| Storage | at -20°C 3 years Powder |
| CAS No. | 946150-57-8 |
| Synonyms | SHP-141 |
| SMILES | O=C(OC)C1=CC=C(OC(CCCCCCC(NO)=O)=O)C=C1 |
Remetinostat (SHP-141) is a hydroxamic acid-based inhibitor of histone deacetylase enzymes (HDAC) which is under development for the treatment of cutaneous T-cell lymphoma.
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 0.1 mM | 30.93 mL | 154.64 mL | 309.27 mL |
| 0.5 mM | 6.19 mL | 30.93 mL | 61.85 mL |
| 1 mM | 3.09 mL | 15.46 mL | 30.93 mL |
| 5 mM | 0.62 mL | 3.09 mL | 6.19 mL |
*The above data is based on the productmolecular weight 323.34. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.
Contact information
United StatesAdooq Bioscience
Toll Free: (866) 930-6790
Fax: +1-323-606-8156
Email: sales@adooq.com
ADOOQ 产品质量保证
We promise all products to perform as described.